Correlation Between ImmunoGen and BridgeBio Pharma
Can any of the company-specific risk be diversified away by investing in both ImmunoGen and BridgeBio Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmunoGen and BridgeBio Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ImmunoGen and BridgeBio Pharma, you can compare the effects of market volatilities on ImmunoGen and BridgeBio Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmunoGen with a short position of BridgeBio Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmunoGen and BridgeBio Pharma.
Diversification Opportunities for ImmunoGen and BridgeBio Pharma
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between ImmunoGen and BridgeBio is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding ImmunoGen and BridgeBio Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BridgeBio Pharma and ImmunoGen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmunoGen are associated (or correlated) with BridgeBio Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BridgeBio Pharma has no effect on the direction of ImmunoGen i.e., ImmunoGen and BridgeBio Pharma go up and down completely randomly.
Pair Corralation between ImmunoGen and BridgeBio Pharma
If you would invest 2,520 in BridgeBio Pharma on September 5, 2024 and sell it today you would earn a total of 190.00 from holding BridgeBio Pharma or generate 7.54% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 4.55% |
Values | Daily Returns |
ImmunoGen vs. BridgeBio Pharma
Performance |
Timeline |
ImmunoGen |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
BridgeBio Pharma |
ImmunoGen and BridgeBio Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ImmunoGen and BridgeBio Pharma
The main advantage of trading using opposite ImmunoGen and BridgeBio Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmunoGen position performs unexpectedly, BridgeBio Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BridgeBio Pharma will offset losses from the drop in BridgeBio Pharma's long position.ImmunoGen vs. Madrigal Pharmaceuticals | ImmunoGen vs. TG Therapeutics | ImmunoGen vs. Terns Pharmaceuticals | ImmunoGen vs. Hepion Pharmaceuticals |
BridgeBio Pharma vs. Blueprint Medicines Corp | BridgeBio Pharma vs. Amylyx Pharmaceuticals | BridgeBio Pharma vs. Day One Biopharmaceuticals | BridgeBio Pharma vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |